Related references
Note: Only part of the references are listed.Dual Resistance to Adamantanes and Oseltamivir Among Seasonal Influenza A(H1N1) Viruses: 2008-2010
Tiffany G. Sheu et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Evidence of Person-to-Person Transmission of Oseltamivir-Resistant Pandemic Influenza A(H1N1) 2009 Virus in a Hematology Unit
Catherine Moore et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Generation and Characterization of Recombinant Pandemic Influenza A(H1N1) Viruses Resistant to Neuraminidase Inhibitors
Andres Pizzorno et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Prophylactic Activity of Intramuscular Peramivir in Mice Infected with a Recombinant Influenza A/WSN/33 (H1N1) Virus Containing the H274Y Neuraminidase Mutation
Yacine Abed et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Detection of the rapid emergence of the H275Y mutation associated with oseltamivir resistance in severe pandemic influenza virus A/H1N1 09 infections
Bin Wang et al.
ANTIVIRAL RESEARCH (2010)
Oseltamivir-resistant influenza A(H1N1) viruses in south of France, 200712009
Jean-Sebastien Casalegno et al.
ANTIVIRAL RESEARCH (2010)
Host cell selection of influenza neuraminidase variants: Implications for drug resistance monitoring in A(H1N1) viruses
Margaret Okomo-Adhiambo et al.
ANTIVIRAL RESEARCH (2010)
Novel influenza A(H1N1) 2009 in vitro reassortant viruses with oseltamivir resistance
Michele Ottmann et al.
ANTIVIRAL THERAPY (2010)
Delayed Clearance of Viral Load and Marked Cytokine Activation in Severe Cases of Pandemic H1N1 2009 Influenza Virus Infection
Kelvin K. W. To et al.
CLINICAL INFECTIOUS DISEASES (2010)
Rapid Selection of Oseltamivir- and Peramivir-Resistant Pandemic H1N1 Virus during Therapy in 2 Immunocompromised Hosts
Matthew J. Memoli et al.
CLINICAL INFECTIOUS DISEASES (2010)
Fatal Respiratory Events Caused by Zanamivir Nebulization
Sumalee Kiatboonsri et al.
CLINICAL INFECTIOUS DISEASES (2010)
Recovery of a Multidrug-Resistant Strain of Pandemic Influenza A 2009 (H1N1) Virus Carrying a Dual H275Y/I223R Mutation from a Child after Prolonged Treatment with Oseltamivir
Ha T. Nguyen et al.
CLINICAL INFECTIOUS DISEASES (2010)
Use of Intravenous Zanamivir after Development of Oseltamivir Resistance in a Critically Ill Immunosuppressed Child Infected with 2009 Pandemic Influenza A (H1N1) Virus
Daniel E. Dulek et al.
CLINICAL INFECTIOUS DISEASES (2010)
Emergence of H5N1 avian influenza viruses with reduced sensitivity to neuraminidase inhibitors and novel reassortants in Lao People's Democratic Republic
David A. Boltz et al.
JOURNAL OF GENERAL VIROLOGY (2010)
End Points for Testing Influenza Antiviral Treatments for Patients at High Risk of Severe and Life-Threatening Disease
Michael G. Ison et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Human Infection with a Triple-Reassortant Swine Influenza A(H1N1) Virus Containing the Hemagglutinin and Neuraminidase Genes of Seasonal Influenza Virus
Nathalie Bastien et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Oseltamivir-Resistant Variants of the 2009 Pandemic H1N1 Influenza A Virus Are Not Attenuated in the Guinea Pig and Ferret Transmission Models
Christopher W. Seibert et al.
JOURNAL OF VIROLOGY (2010)
The Case for Integrated Delivery Systems
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Emergence of a Multidrug-Resistant Pandemic Influenza A (H1N1) Virus.
Erhard van der Vries et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Intravenous Zanamivir for Oseltamivir-Resistant 2009 H1N1 Influenza
Aditya H. Gaur et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Triple Combination of Amantadine, Ribavirin, and Oseltamivir Is Highly Active and Synergistic against Drug Resistant Influenza Virus Strains In Vitro
Jack T. Nguyen et al.
PLOS ONE (2010)
Permissive Secondary Mutations Enable the Evolution of Influenza Oseltamivir Resistance
Jesse D. Bloom et al.
SCIENCE (2010)
Early Pandemic Influenza (2009 H1N1) in Ho Chi Minh City, Vietnam: A Clinical Virological and Epidemiological Analysis
Tran Tinh Hien et al.
PLOS MEDICINE (2010)
Pandemic (H1N1) 2009 and Seasonal Influenza A (H1N1) Co-infection, New Zealand, 2009
Matthew Peacey et al.
EMERGING INFECTIOUS DISEASES (2010)
Oseltamivir Resistance in Adult Oncology and Hematology Patients Infected with Pandemic (H1N1) 2009 Virus, Australia
Adrian R. Tramontana et al.
EMERGING INFECTIOUS DISEASES (2010)
Oseltamivir- and Amantadine-Resistant Influenza Virus A (H1N1)
Peter K. C. Cheng et al.
EMERGING INFECTIOUS DISEASES (2010)
In Vitro Generation of Neuraminidase Inhibitor Resistance in A(H5N1) Influenza Viruses
Aeron C. Hurt et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Effects of Double Combinations of Amantadine, Oseltamivir, and Ribavirin on Influenza A (H5N1) Virus Infections in Cell Culture and in Mice
Donald F. Smee et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania, South East Asia and South Africa
Aeron C. Hurt et al.
ANTIVIRAL RESEARCH (2009)
Neuraminidase Inhibitor Resistance after Oseltamivir Treatment of Acute Influenza A and B in Children
Iain Stephenson et al.
CLINICAL INFECTIOUS DISEASES (2009)
Morbidity and Mortality Associated With Nosocomial Transmission of Oseltamivir-Resistant Influenza A(H1N1) Virus
Jairo Gooskens et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Infections With Oseltamivir-Resistant Influenza A(H1N1) Virus in the United States
Nila J. Dharan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Prolonged Influenza Virus Infection during Lymphocytopenia and Frequent Detection of Drug-Resistant Viruses
Jairo Gooskens et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Zanamivir-Resistant Influenza Viruses with a Novel Neuraminidase Mutation
Aeron C. Hurt et al.
JOURNAL OF VIROLOGY (2009)
H1N1 pneumonitis treated with intravenous zanamivir
I. Michael Kidd et al.
LANCET (2009)
Structural basis for oseltamivir resistance of influenza viruses
P. J. Collins et al.
VACCINE (2009)
The origin and global emergence of adamantane resistant A/H3N2 influenza viruses
Martha I. Nelson et al.
VIROLOGY (2009)
Oseltamivir resistance mutation N294S in human influenza A(H5N1) virus in Egypt
Kenneth C. Earhart et al.
Journal of Infection and Public Health (2009)
Oseltamivir-Resistant Influenza A Pandemic (H1N1) 2009 Virus, Hong Kong, China
Honglin Chen et al.
EMERGING INFECTIOUS DISEASES (2009)
Oseltamivir- and Amantadine-Resistant Influenza Viruses A (H1N1)
Peter K. C. Cheng et al.
EMERGING INFECTIOUS DISEASES (2009)
Oseltamivir-Ribavirin Combination Therapy for Highly Pathogenic H5N1 Influenza Virus Infection in Mice
Natalia A. Ilyushina et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Enzymatic properties of the neuraminidase of seasonal H1N1 influenza viruses provide insights for the emergence of natural resistance to oseltamivir
Marie-Anne Rameix-Welti et al.
PLOS PATHOGENS (2008)
Generation and characterization of recombinant influenza A (H1N1) viruses harboring amantadine resistance mutations
Y Abed et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Influenza viruses resistant to the antiviral drug oseltamivir: Transmission studies in ferrets
ML Herlocher et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo
JAL Ives et al.
ANTIVIRAL RESEARCH (2002)
Selection of influenza virus mutants in experimentally infected volunteers treated with oseltamivir
LV Gubareva et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Share Paper
